Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 132.50
-1.50 (-1.12%)
Mar 9, 2026, 3:00 PM CST
Beijing Hotgen Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 407.69 | 505.01 | 544.62 | 3,532 | 5,307 | Upgrade
|
| Other Revenue | - | 5.89 | 3.22 | 24.41 | 62.65 | Upgrade
|
| Revenue | 407.69 | 510.9 | 547.84 | 3,557 | 5,369 | Upgrade
|
| Revenue Growth (YoY) | -20.20% | -6.74% | -84.60% | -33.76% | 945.54% | Upgrade
|
| Cost of Revenue | - | 257.18 | 211.72 | 1,766 | 2,254 | Upgrade
|
| Gross Profit | 407.69 | 253.72 | 336.11 | 1,790 | 3,116 | Upgrade
|
| Selling, General & Admin | - | 289.77 | 258.6 | 483.58 | 404.26 | Upgrade
|
| Research & Development | - | 113.31 | 132.88 | 191.14 | 131.92 | Upgrade
|
| Other Operating Expenses | 670.27 | 3.45 | 3.58 | 9.2 | 5.04 | Upgrade
|
| Operating Expenses | 670.27 | 407.9 | 381.66 | 695.26 | 541.92 | Upgrade
|
| Operating Income | -262.58 | -154.18 | -45.55 | 1,095 | 2,574 | Upgrade
|
| Interest Expense | - | -0.45 | -1.01 | -2.32 | -1.27 | Upgrade
|
| Interest & Investment Income | - | 32.85 | 39.59 | 34.52 | 34.26 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.78 | 4.31 | 4.95 | -14.64 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.19 | 0.24 | -1.27 | 3.31 | -4.82 | Upgrade
|
| EBT Excluding Unusual Items | -264.77 | -122.32 | -3.92 | 1,135 | 2,587 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -9.36 | -23.68 | 7.52 | 3.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -1.63 | -0.64 | -0.34 | -14.21 | Upgrade
|
| Asset Writedown | - | -60.85 | -41.79 | -70.06 | -8.51 | Upgrade
|
| Other Unusual Items | - | 6.29 | 85.02 | 2.63 | 14.22 | Upgrade
|
| Pretax Income | -264.77 | -187.87 | 14.99 | 1,075 | 2,582 | Upgrade
|
| Income Tax Expense | -54.25 | 8.06 | -1.73 | 150.1 | 379.44 | Upgrade
|
| Earnings From Continuing Operations | -210.52 | -195.94 | 16.71 | 925.12 | 2,202 | Upgrade
|
| Minority Interest in Earnings | - | 4.93 | 12.21 | 19.62 | -16.61 | Upgrade
|
| Net Income | -210.52 | -191 | 28.92 | 944.74 | 2,186 | Upgrade
|
| Net Income to Common | -210.52 | -191 | 28.92 | 944.74 | 2,186 | Upgrade
|
| Net Income Growth | - | - | -96.94% | -56.78% | 1850.41% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 92 | 88 | 91 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 92 | 88 | 92 | 92 | Upgrade
|
| Shares Change (YoY) | 1.73% | 4.59% | -3.88% | -0.14% | -0.12% | Upgrade
|
| EPS (Basic) | -2.24 | -2.07 | 0.33 | 10.33 | 23.75 | Upgrade
|
| EPS (Diluted) | -2.24 | -2.07 | 0.33 | 10.28 | 23.75 | Upgrade
|
| EPS Growth | - | - | -96.81% | -56.72% | 1852.80% | Upgrade
|
| Free Cash Flow | - | -88.57 | -461.9 | 413.54 | 2,246 | Upgrade
|
| Free Cash Flow Per Share | - | -0.96 | -5.23 | 4.50 | 24.40 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | - | 3.378 | Upgrade
|
| Dividend Growth | - | - | - | - | 233.34% | Upgrade
|
| Gross Margin | 100.00% | 49.66% | 61.35% | 50.34% | 58.03% | Upgrade
|
| Operating Margin | -64.41% | -30.18% | -8.31% | 30.79% | 47.93% | Upgrade
|
| Profit Margin | -51.64% | -37.39% | 5.28% | 26.56% | 40.71% | Upgrade
|
| Free Cash Flow Margin | - | -17.34% | -84.31% | 11.63% | 41.82% | Upgrade
|
| EBITDA | -178.24 | -69.84 | 15.66 | 1,184 | 2,631 | Upgrade
|
| EBITDA Margin | -43.72% | -13.67% | 2.86% | 33.30% | 49.00% | Upgrade
|
| D&A For EBITDA | 84.33 | 84.33 | 61.2 | 89.39 | 57.5 | Upgrade
|
| EBIT | -262.58 | -154.18 | -45.55 | 1,095 | 2,574 | Upgrade
|
| EBIT Margin | -64.41% | -30.18% | -8.31% | 30.79% | 47.93% | Upgrade
|
| Effective Tax Rate | - | - | - | 13.96% | 14.70% | Upgrade
|
| Revenue as Reported | - | 510.9 | 547.84 | 3,557 | 5,369 | Upgrade
|
| Advertising Expenses | - | 15.59 | 13.38 | 55.08 | 68.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.